ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2024-2031³â)
Emergency Contraceptive Pills Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031
»óǰÄÚµå : 1595687
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2024³â 11¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 170 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,227,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,555,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 12,291,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

ÁÖ¿ä ÀλçÀÌÆ®

ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå - ¸®Æ÷Æ® ¹üÀ§

ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå¿¡´Â ÇÇÀÓ ¾øÀÌ ¼º°ü°è¸¦ °¡Áø ÈÄ ÀÓ½ÅÀ» ¿¹¹æÇÏ´Â µ¥ »ç¿ëµÇ´Â ´Ù¾çÇÑ Á¦Ç°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ ½ÃÀå¿¡´Â º¹ÇÕ ÇÇÀÓ¾à, ÇÁ·Î°Ô½ºÅ×·Ð Àü¿ë ÇÇÀÓ¾à ¹× ±âŸ ÀÀ±Þ ÇÇÀÓ¾àÀÌ Æ÷ÇԵ˴ϴÙ. µµ½ÃÈ­ÀÇ ÁøÀü°ú¼º °Ç°­ ±Ô¹üÀÇ º¯È­¿¡µµ ºÒ±¸Çϰí ÇÇÀÓ¾à º¹¿ëÀÇ ½Ã°£Àû Á¦¾à°ú ÀÀ±ÞÇÇÀÓ¾àÀÇ ºÎÀÛ¿ë°ú °°Àº ¿äÀÎÀÌ ½ÃÀå ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀϺΠÁö¿ª¿¡¼­´Â »çȸÀû ³«ÀÎ, ÀÎ½Ä ºÎÁ·, ÀûÀýÇÑ ÇÇÀÓ ¿É¼Ç¿¡ ´ëÇÑ Á¦ÇÑµÈ Á¢±Ù¼º µîÀÌ ÀÌ·¯ÇÑ Á¦Ç°ÀÇ Ã¤ÅÃÀ» ´õ¿í ¾î·Æ°Ô ¸¸µé°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

½ÃÀå ¼ºÀåÀº¼º °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ÀÇ·á±â°üÀÇ Áö¿ø, ´õ ³ªÀº °¡Á· °èȹ ¹æ¹ýÀÇ È«º¸¿Í °°Àº ¿äÀο¡ ÀÇÇØ Çü¼ºµÇ°í ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â International Consortium for Emergency Contraception°ú °°Àº ´ÜüÀÇ Áö¿øÀ¸·Î ÀÎÇØ ÀÀ±ÞÇÇÀÓ¾àÀÇ Áß¿äÇÑ ½ÃÀåÀ¸·Î ³²À» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¸¹Àº »ç¿ëÀÚµéÀÌ ºÎÀÛ¿ë°ú ½Ã°£°úÀÇ ½Î¿òÀ̶ó´Â Á¦Ç° Ư¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ Ç¥¸íÇϰí ÀÖÀ¸¸ç, º¸±ÞÀÌ Á¦ÇÑÀûÀ̾ ¼ºÀåÀÌ Á¦ÇÑÀûÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ

ÀÀ±ÞÇÇÀÓ¾à ½ÃÀåÀÌ Á÷¸éÇÑ ¹®Á¦·Î´Â Àû½Ã º¹¿ë¿¡ ´ëÇÑ ³ôÀº ÀÇÁ¸µµ, ¸Þ½º²¨¿ò, ºÎÁ¤ÃâÇ÷°ú °°Àº ºÎÀÛ¿ë, ¼ºº´(STI) ¿¹¹æ È¿°úÀÇ ºÎÁ· µîÀÌ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÇÀÓ¾àÀº ¼ºº´À» ¿¹¹æÇÏÁö ¸øÇϹǷΠÀϺΠºÎ¹®¿¡¼­ È£¼Ò·ÂÀÌ ¶³¾îÁö°í ÀÖ½À´Ï´Ù. ÀÀ±ÞÇÇÀÓ¾àÀÌ ÀÏ¹Ý ÇÇÀӾ࿡ ºñÇØ ´ú ¼±È£µÇ´Â ¼±ÅÃÀ̶ó´Â ÀνÄÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í ¾ïÁ¦Çϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ

ÀÌ·¯ÇÑ ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀο¡µµ ºÒ±¸ÇÏ°í ºÎÀÛ¿ëÀÌ ÀûÀº ÀÀ±ÞÇÇÀÓ¾àÀÇ °³¹ß·Î ÀÎÇØ ½ÃÀå º¸±Þ·üÀÌ ³ô¾ÆÁú °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. Á¦Á¶¾÷üµéÀº °³¼±µÈ Á¦Çü °³¹ß¿¡ ÁýÁßÇϰí ÀÖÀ¸¸ç, º´¿ø ¾à±¹ ¹× Á¶Á÷È­µÈ ¼Ò¸Å ä³ÎÀ» ÅëÇØ ½±°Ô ±¸ÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ NGO ¹× Á¤ºÎ ±â°üÀÇ ±³À° Ȱµ¿ °­È­´Â ¿ÀÇØ¸¦ ÇØ¼ÒÇÏ°í ¾ÈÀüÇÑ ÀÀ±ÞÇÇÀÓ¾à »ç¿ëÀ» ÃËÁøÇϱâ À§ÇÑ °ÍÀÔ´Ï´Ù.

¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå¿¡ ´ëÇØ Á¶»çºÐ¼®ÇßÀ¸¸ç, ÃËÁø¿äÀÎ, »õ·Î¿î µ¿Çâ, °úÁ¦, ÇâÈÄ ±âȸ µîÀÇ »ó¼¼ÇÑ ºÐ¼®À» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå °³¿ä

Á¦3Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Á¦Ç° À¯Çüº°

Á¦4Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ÆÇ¸Åä³Îº°

Á¦5Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : Áö¿ªº°

Á¦6Àå ºÏ¹ÌÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦7Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦8Àå À¯·´ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦9Àå ÀϺ»ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾ç(ÀϺ» Á¦¿Ü) ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ºÐ¼®°ú ¿¹Ãø : ±¹°¡º°(2024-2031³â)

Á¦12Àå ¼¼°èÀÇ ÀÀ±ÞÇÇÀÓ¾à ½ÃÀå ±â¾÷/Á¦Á¶¾÷ü/ÆÇ¸Å¾÷ü/°ø±Þ¾÷ü °³¿ä¿Í ¸ÅÃâ ¿¹Ãø

Á¦13Àå Á¶»ç ¹æ¹ý

Á¦14Àå 2Â÷ ÀÚ·á¿Í 1Â÷ ÀÚ·á

Á¦15Àå ÀüÁ¦Á¶°Ç°ú µÎÀÚ¾î

Á¦16Àå ¸éÃ¥»çÇ×

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the global Emergency Contraceptive Pills Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, challenges, and future opportunities. This report offers a detailed overview of the market landscape, supporting stakeholders in making well-informed decisions.

Key Insights:

Emergency Contraceptive Pills Market - Report Scope:

The Emergency Contraceptive Pills market encompasses a range of products used to prevent pregnancy following unprotected intercourse. This market includes combination pills, progesterone-only pills, and other emergency contraceptives. Despite increasing urbanization and changing sexual health norms, factors like time constraints for pill intake and side effects associated with emergency contraceptive pills are expected to impact the market's growth negatively. Social stigmas, lack of awareness, and limited access to proper contraceptive options in some regions further challenge the adoption of these products.

Market Drivers:

The market's growth is being shaped by factors such as the increasing awareness about sexual health, support from healthcare organizations, and the drive for better family planning methods. North America is projected to remain a significant market for emergency contraceptive pills due to advocacy from organizations like the International Consortium for Emergency Contraception. However, growth is limited as many users express concerns over side effects and the time-sensitive nature of these products, which discourages widespread adoption.

Market Restraints:

Challenges facing the Emergency Contraceptive Pills market include high reliance on timely intake, side effects like nausea and irregular bleeding, and the lack of efficacy in preventing sexually transmitted infections (STIs). These pills do not protect against venereal diseases, which reduces their appeal in some segments. The perception of emergency contraception as a less-preferred option compared to regular contraceptives further constrains the market's growth.

Market Opportunities:

Despite these restraints, the market presents opportunities through the development of emergency contraceptives with fewer side effects, which could encourage higher adoption. Manufacturers are focusing on creating improved formulations and expanding accessibility through hospital pharmacies and organized retail channels. Furthermore, increased educational initiatives by NGOs and government agencies aim to address misconceptions and promote safe emergency contraceptive practices.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading companies in the Emergency Contraceptive Pills market, including Bayer AG, Teva Pharmaceutical Industries Ltd., and Pfizer Inc., focus on research and development to improve product efficacy and reduce side effects. Partnerships with healthcare providers and initiatives to enhance accessibility are pivotal for their market presence. These companies emphasize affordability, safety, and effective marketing to improve product perception, which is crucial for competing in this challenging market.

Key Companies Profiled:

Emergency Contraceptive Pills Market Segmentation:

By Product Type:

By Sales Channel:

By Region:

Table of Contents

1. Executive Summary

2. Global Emergency Contraceptive Pills Market Overview

3. Global Emergency Contraceptive Pills Market Analysis and Forecast By Product Type

4. Global Emergency Contraceptive Pills Market Analysis and Forecast By Sales Channel

5. Global Emergency Contraceptive Pills Market Analysis and Forecast By Region

6. North America Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

7. Latin America Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

8. Europe Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

9. Japan Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

10. APEJ Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

11. MEA Emergency Contraceptive Pills Market Analysis and Forecast, By Country, 2024-2031

12. Global Emergency Contraceptive Pills Market Company/Manufactures/Distributors/Suppliers Profile and Revenue Projections

13. Research Methodology

14. Secondary and Primary Sources

15. Assumptions and Acronyms

16. Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â